Cerity Partners
WGS icon

Cerity Partners’s GeneDx Holdings WGS Stock Holding History

Cerity Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,527
Closed -$329K – 3403
2025
Q4 		$329K Buy
2,527
+142
+6% +$19.5K ﹤0.01% 2359
2025
Q3 		$257K Buy
2,385
+103
+5% +$11.2K ﹤0.01% 2387
2025
Q2 		$211K Sell
2,282
-277
-11% -$21.7K ﹤0.01% 2327
2025
Q1 		$227K Buy
+2,559
New +$222K ﹤0.01% 2158

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cerity Partners's WGS Position: Q1 2026 in Review

Cerity Partners sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 2,527 shares — an estimated $329K sold.

Cerity Partners first reported a position in WGS in Q1 2025 and held it in 4 quarters. The position peaked at $329K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Cerity Partners reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 2,527 GeneDx Holdings shares in Q1 2026, an estimated $329K.
  • Cerity Partners first reported a position in GeneDx Holdings in Q1 2025 and held it in 4 quarters.
  • Cerity Partners's GeneDx Holdings position peaked at $329K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.